ProfileGDS4177 / 235846_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 66% 67% 74% 77% 52% 55% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated76.566
GSM603099KU-812 non-treated80.3467
GSM603098KCL-22 Imatinib-treated140.5474
GSM603097KCL-22 non-treated172.0477
GSM603102JURL-MK1 Imatinib-treated35.7652
GSM603101JURL-MK1 non-treated40.5555